Johnson & Johnson in talks to acquire Protagonist Therapeutics, source says

新聞報導於1天前

撰寫摘要中...

您可能也對這些小見聞有興趣

中國加強對某些稀土和相關技術的出口限制

匯豐計畫以370億美元估值私有化恆生銀行

AIRO Group Holdings, Inc. (AIRO) Joins Russell 2000 and Russell 3000 Indexes

The Fed still hasn’t defeated high inflation. Has it failed?

Is GE Vernova (GEV) the Best Nuclear Energy Stock to Buy Now?

CEO: AI and defense demand are remaking the space economy

Fed's Williams backs more rate cuts this year due to labor market slowdown risks, he tells NYT

Flipkart’s Super.money quietly partners with troubled Juspay as it expands its reach

Bristol Myers Squibb’s Alzheimer’s Drug, BMS-986446, Granted FDA Fast Track Status

返回所有小見聞